NCT07480070

Brief Summary

Introduction: Resin composite restorations are among the most commonly used materials for restoring posterior teeth due to their aesthetic and mechanical properties. Self-cured resin composites have emerged as a promising option to overcome some of the limitations of conventional light-cured composites. Aim: The aim of this study is to evaluate the effect of self-cured resin composite in restoring occlusal cavities of posterior teeth over a period of two years. The results will contribute to clarifying its efficiency and safety as a treatment option in daily clinical practice. Research Steps: Fifty affected teeth will be selected and randomly allocated into groups. Group (A): Self-cured resin composite group - self-cured resin composite will be used. Group (B): Bioactive nano-hybrid resin composite group - bioactive nano-hybrid resin composite will be used. The restorations will be evaluated after placement. Introduction: Resin composite restorations are among the most widely used materials in restorative dentistry due to their favorable aesthetic and physical properties. However, the success of these restorations largely depends on the type of material used and the technique of application. Conventional light-cured composites are the most common option, yet they may present certain limitations in cases where adequate isolation is difficult to achieve or in posterior areas of the mouth. In contrast, self-cured resin composites have emerged as a promising alternative because of their ability to polymerize chemically without the need for a light source. These materials are characterized by ease of use and the possibility of application under limited clinical conditions, making them suitable in certain clinical situations. Aim of the Study: The aim of this randomized controlled clinical trial is to evaluate the clinical performance of a newly introduced self-cured resin composite (Stela, SDI, Australia) in class I occlusal cavities of posterior teeth compared to light-cured Nano-hybrid bioactive resin composite (Beautifill II, Shofu, Japan) regarding functional properties over a follow-up of 2 years. Research Question: Does the clinical performance of self-cured resin composite restorations differ from light cured nano-hybrid bioactive resin composite in class I cavities?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 3, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 18, 2026

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

1 month

First QC Date

March 3, 2026

Last Update Submit

March 14, 2026

Conditions

Keywords

Class I cavitiesClinical PerformanceFDI criteriaSelf cured resin compositeOcclusal cavitiesTwo-YearLight cured resin compositeBioactive resin composite

Outcome Measures

Primary Outcomes (1)

  • Functional properties as assisted by FDI criteria for direct restorations

    Unit of measurement is numbers and percentages

    2 years

Study Arms (2)

Bioactive Nano-hybrid composite group

ACTIVE COMPARATOR
Procedure: Bioactive Nano-hybrid composite

Self-cured composite group

EXPERIMENTAL
Procedure: Self Cured Composite

Interventions

After cavity disinfection, Selective etching of enamel will be done using 37% phosphoric acid etch on all enamel margins after protection of dentin for 20 seconds followed by rinsing and dryness. Then, a universal adhesive will be applied using micro brush on all cavity (Enamel and Dentin). A gentle air blast will be done for the adhesive for 5 seconds then cured for 20 seconds according to the manufacturer instructions. A thin layer (1mm) of highly filled flowable composite will be applied on the cavity floor and distributed using the tip of the explorer then cured for 20 seconds according to the manufacturer instructions. Finally, nano hybrid composite will be packed incrementally following the tooth anatomy and each increment will be cured for 20 seconds according to the manufacturer instructions. For both groups sequential finishing and polishing will be done using red and yellow coded finishing stones, polishing tips and polishing paste according to the manufacturer instructions.

Bioactive Nano-hybrid composite group

After cavity disinfection, the adhesive protocol system will be applied on the cavity and margins according to the manufacturer instructions using Stela primer then stela composite will be applied in single increment covering the margins. A period of 4 minutes is required till complete setting before starting finishing and polishing procedures

Self-cured composite group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients typically between 18 to 50 years old.
  • Males or Females.
  • Co-operative patients approving the trial.
  • Good oral hygiene.

You may not qualify if:

  • Lack of compliance.
  • Patients with bad oral hygiene.
  • Patients who are allergic to any ingredients used in the study.
  • Medically compromised patients with systemic complications that would alter the treatment.
  • Inability to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The British University in Egypt

Cairo, Elshorouk City, 4914085, Egypt

Location

MeSH Terms

Interventions

Palfique self-cured composite

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 3, 2026

First Posted

March 18, 2026

Study Start

January 1, 2026

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations